Lung Cancer highlights of ESMO 2023 Congress

from Medical Digest & Congress Report · host Medical Congress News

Professor Luis Paz-Ares explains the most important novelties in the field of lung cancer treatement after ESMO 2023. - Early stage trails: ADAURA, ALINA, CheckMate 816, Keynote 671, CheckMate 017 - Stage III trial: PACIFIC-6 - STAGE IV trials: LIBRETTO-431, MARIPOSA, MARIPOSA-2, TROPION-Lung01 Video: https://medicaldigest.org/scientific-contents/interview:lung-cancer-highlights-esmo-2023-congress-2

Episode metadata supplied by the publisher feed · Published Nov 29, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Lung Cancer highlights of ESMO 2023 Congress

0:00 13:28

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 13 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on November 29, 2023.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!